Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F22%3A00013401" target="_blank" >RIV/00023736:_____/22:00013401 - isvavai.cz</a>
Alternative codes found
RIV/00064173:_____/22:43921842 RIV/00216208:11120/22:43921842 RIV/00216224:14110/22:00129735
Result on the web
<a href="https://doi.org/10.3324/haematol.2021.278645" target="_blank" >https://doi.org/10.3324/haematol.2021.278645</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3324/haematol.2021.278645" target="_blank" >10.3324/haematol.2021.278645</a>
Alternative languages
Result language
angličtina
Original language name
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study
Original language description
The aim of this study was to evaluate the prognostic impact of FLT3-ITD in core-binding factor acute myeloid leukemia (CBFAML) in an international, multicenter survey of 97 patients. The median age of the patients was 53 years (range, 19-81). Complete remission after anthracycline-based induction (n=86) and non-intensive therapy (n=11) was achieved in 97% and 36% of the patients, respectively. The median follow-up was 4.43 years (95% confidence interval [95% CI]: 3.35-7.39 years). The median survival after intensive and non-intensive treatment was not reached and 0.96 years, respectively.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
<a href="/en/project/NV15-25809A" target="_blank" >NV15-25809A: National study of leukemia cell mutations and clonality in patients diagnosed with acute myeloid leukemia</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Haematologica
ISSN
0390-6078
e-ISSN
—
Volume of the periodical
107
Issue of the periodical within the volume
4
Country of publishing house
IT - ITALY
Number of pages
8
Pages from-to
836-843
UT code for WoS article
000577160406074
EID of the result in the Scopus database
2-s2.0-85127922810